What is Innovation Countdown 2030?
Innovation Countdown 2030 (IC2030) is reimagining what’s possible in global health. Led by PATH, the initiative is creating a platform to identify, evaluate, and showcase high-impact technologies and interventions that can transform global health by 2030.
The initiative is supported by the Norwegian Agency for Development Cooperation, the Bill & Melinda Gates Foundation, and the US Agency for International Development.
By engaging entrepreneurs, investors, innovators, and experts across sectors and around the world, IC2030 aims to raise awareness of and support for high-potential innovations to catalyze investment and accelerate health solutions with the greatest promise to save lives.
PATH leads the IC2030 initiative, building on our nearly four decades of experience in translating bold ideas into breakthrough health solutions.
PATH is the leader in global health innovation. An international nonprofit organization, we save lives and improve health, especially among women and children. We accelerate innovation across five platforms—vaccines, drugs, diagnostics, devices, and system and service innovations—that harness our entrepreneurial insight, scientific and public health expertise, and passion for health equity.
By mobilizing partners around the world, we take innovation to scale, working alongside countries primarily in Africa and Asia to tackle their greatest health needs. Together, we deliver measurable results that disrupt the cycle of poor health.
With headquarters in Seattle, Washington, PATH has 1,300 employees and offices in 20 countries. Learn more at www.path.org.
Photo: PATH/Evelyn Hockstein.